The regulatory role of the PI3K signaling pathway towards MYCN has been established in neuroblastoma previously, suggesting the PI3K signaling pathway as potential targets for neuroblastoma treatment [19]. The gene discussed is PIK3CB; the disease is neuroblastoma.